bluebird bio (BLUE) PT Lowered to $14 at BofA Securities
Tweet
Share
E-mailGet Alerts BLUE Hot Sheet
Price: $0.92 -5.15%
Rating Summary:
13 Buy, 16 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 14
Rating Summary:
13 Buy, 16 Hold, 3 Sell
Rating Trend:
Down
Today's Overall Ratings:
Up: 12 | Down: 10 | New: 14
Join SI Premium – FREE
BofA Securities analyst Jason Gerberry lowered the price target on bluebird bio (NASDAQ: BLUE) to $14.00 (from $22.00) while maintaining a Neutral rating.
You May Also Be Interested In
- BLUEBIRD BIO, INC. (NASDAQ: BLUE) DEADLINE ALERT: Bernstein Liebhard LLP Reminds bluebird bio, Inc. Investors of Upcoming Deadline
- UCB SA (UCB:BB) (UCBJY) PT Raised to EUR135 at HSBC
- UBS Downgrades Hino Motors Ltd. (7205:JP) (HINOY) to Neutral
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
